<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19-infected patients have a worse prognosis when they suffer from comorbidities, especially cardiovascular. RAS inhibitors have been shown to have a protective effect on the kidney and myocardium, and it may therefore be dangerous to withdraw treatment in these patients. A higher risk of relapse in patients with cardiovascular or renal disease has also been demonstrated.
 <sup>
  <xref rid="bibr54-0004563220928361" ref-type="bibr">54</xref>
 </sup>
</p>
